NEKTAR THERAPEUTICS Annual Return On Assets in % from 2011 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Nektar Therapeutics quarterly/annual Return On Assets history and growth rate from 2011 to 2023.
  • Nektar Therapeutics Return On Assets for the quarter ending June 30, 2024 was -44.8 %, a 6.93% increase year-over-year.
  • Nektar Therapeutics annual Return On Assets for 2023 was -58.2 %, a 33.6% decline from 2022.
  • Nektar Therapeutics annual Return On Assets for 2022 was -43.6 %, a 8.67% decline from 2021.
  • Nektar Therapeutics annual Return On Assets for 2021 was -40.1 %, a 47.4% decline from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -58.2 -14.6 -33.6% Jan 1, 2023 Dec 31, 2023
2022 -43.6 -3.48 -8.67% Jan 1, 2022 Dec 31, 2022
2021 -40.1 -12.9 -47.4% Jan 1, 2021 Dec 31, 2021
2020 -27.2 -6.07 -28.7% Jan 1, 2020 Dec 31, 2020
2019 -21.2 -59 -156% Jan 1, 2019 Dec 31, 2019
2018 37.8 +56.3 Jan 1, 2018 Dec 31, 2018
2017 -18.5 +13.1 +41.4% Jan 1, 2017 Dec 31, 2017
2016 -31.5 -14.5 -84.7% Jan 1, 2016 Dec 31, 2016
2015 -17.1 -5.61 -49% Jan 1, 2015 Dec 31, 2015
2014 -11.5 +27.2 +70.4% Jan 1, 2014 Dec 31, 2014
2013 -38.6 -10 -34.9% Jan 1, 2013 Dec 31, 2013
2012 -28.6 -8.24 -40.4% Jan 1, 2012 Dec 31, 2012
2011 -20.4 Jan 1, 2011 Dec 31, 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.